The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: A cross-sectional study

Reproductive Biology and Endocrinology

Volumn 8, Issue , 2010, Pages

  Panidis, Dimitrios ^a   Tziomalos, Konstantinos ^a   Koiou, Ekaterini ^a   Kandaraki, Eleni A ^a   Tsourdi, Elena ^a   Delkos, Dimitrios ^a   Kalaitzakis, Emmanuil ^a   Katsikis, Ilias ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OBESITY; OVARY POLYCYSTIC DISEASE; PROTEIN BLOOD LEVEL; BLOOD; CROSS-SECTIONAL STUDY; INSULIN RESISTANCE;

ACUTE-PHASE PROTEINS; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOCALINS; OBESITY; OVERWEIGHT; POLYCYSTIC OVARY SYNDROME; PROTO-ONCOGENE PROTEINS;

EID: 78649780858     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-8-151     Document Type: Article

References (47)

1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19:41-47. 10.1093/humrep/deh098, 14688154, Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
3. Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, O'Keefe M, Ghazzi MN, . PCOS/Troglitazone Study Group Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2001, 86:1626-1632. 10.1210/jc.86.4.1626, 11297595, PCOS/Troglitazone Study Group.
4. Legato MJ. Gender-specific aspects of obesity. Int J Fertil Womens Med 1997, 42:184-197.
5. Björntorp P. Abdominal obesity and the metabolic syndrome. Ann Med 1992, 24:465-468.
6. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997, 18:774-800. 10.1210/er.18.6.774, 9408743.
7. Goodarzi MO, Korenman SG. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril 2003, 80:255-258. 10.1016/S0015-0282(03)00734-9, 12909480.
8. Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab 1997, 82:4075-4079. 10.1210/jc.82.12.4075, 9398716.
9. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991, 72:83-89. 10.1210/jcem-72-1-83, 1898744.
10. Deslypere JP, Verdonck L, Vermeulen A. Fat tissue: a steroid reservoir and site of steroid metabolism. J Clin Endocrinol Metab 1985, 61:564-570. 10.1210/jcem-61-3-564, 3160722.
11. Peltoketo H, Luu-The V, Simard J, Adamski J. 17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol 1999, 23:1-11. 10.1677/jme.0.0230001, 10431140.
12. Triebel S, Bläser J, Reinke H, Tschesche H. A 25 kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett 1992, 314:386-388. 10.1016/0014-5793(92)81511-J, 1281792.
13. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993, 268:10425-10432.
14. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997, 45:17-23. 10.1006/geno.1997.4896, 9339356.
15. Kratchmarova I, Kalume DE, Blagoev B, Scherer PE, Podtelejnikov AV, Molina H, Bickel PE, Andersen JS, Fernandez MM, Bunkenborg J, Roepstorff P, Kristiansen K, Lodish HF, Mann M, Pandey A. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002, 1:213-222. 10.1074/mcp.M200006-MCP200, 12096121.
16. Liu Q, Nilsen-Hamilton M. Identification of a new acute phase protein. J Biol Chem 1995, 270:22565-22570. 10.1074/jbc.270.38.22565, 7545679.
17. Meheus LA, Fransen LM, Raymackers JG, Blockx HA, Van Beeumen JJ, Van Bun SM, Van de Voorde A. Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. J Immunol 1993, 151:1535-1547.
18. Sunil VR, Patel KJ, Nilsen-Hamilton M, Heck DE, Laskin JD, Laskin DL. Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Exp Mol Pathol 2007, 83:177-187. 10.1016/j.yexmp.2007.03.004, 17490638.
19. Bu DX, Hemdahl AL, Gabrielsen A, Fuxe J, Zhu C, Eriksson P, Yan ZQ. Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB. Am J Pathol 2006, 169:2245-2253. 10.2353/ajpath.2006.050706, 1762469, 17148685.
20. Jayaraman A, Roberts KA, Yoon J, Yarmush DM, Duan X, Lee K, Yarmush ML. Identification of neutrophil gelatinase-associated lipocalin (NGAL) as a discriminatory marker of the hepatocyte-secreted protein response to IL-1beta: a proteomic analysis. Biotechnol Bioeng 2005, 91:502-515. 10.1002/bit.20535, 15918168.
21. Huang HL, Chu ST, Chen YH. Ovarian steroids regulate 24p3 expression in mouse uterus during the natural estrous cycle and the preimplantation period. J Endocrinol 1999, 162:11-19. 10.1677/joe.0.1620011, 10396016.
22. Devireddy LR, Teodoro JG, Richard FA, Green MR. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 2001, 293:829-834. 10.1126/science.1061075, 11486081.
23. Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AW, Chow WS, Wat NM, Xu JY, Hoo RL, Xu A. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007, 53:34-41. 10.1373/clinchem.2006.075614, 17040956.
24. Choi KM, Lee JS, Kim EJ, Baik SH, Seo HS, Choi DS, Oh DJ, Park CG. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol 2008, 158:203-207. 10.1530/EJE-07-0633, 18230827.
25. Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab 2009, 296:E238-243. 10.1152/ajpendo.90684.2008, 18957615.
26. Morley JE, Patrick P, Perry HM. Evaluation of assays available to measure free testosterone. Metabolism 2002, 5:554-559.
27. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:12-19. 10.1007/BF00280883, 3979681.
28. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410. 10.1210/jc.85.7.2402, 10902785.
29. Devarajan P. Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury. Nephrol Dial Transplant 2008, 23:3737-3743. 10.1093/ndt/gfn531, 2720816, 18809975.
30. Pervaiz S, Brew K. Homology of beta-lactoglobulin, serum retinol-binding protein, and protein HC. Science 1985, 228:335-337. 10.1126/science.2580349, 2580349.
31. Pervaiz S, Brew K. Homology and structure-function correlations between alpha 1-acid glycoprotein and serum retinol-binding protein and its relatives. FASEB J 1987, 1:209-214.
32. Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR, Raymond KN, Wanner BL, Strong RK, Walsh CT, Aderem A, Smith KD. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA 2006, 103:16502-16507. 10.1073/pnas.0604636103, 1637611, 17060628.
33. Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, Du T, Erdjument-Bromage H, Tempst P, Strong R, Barasch J. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002, 10:1045-1056. 10.1016/S1097-2765(02)00710-4, 12453413.
34. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432:917-921. 10.1038/nature03104, 15531878.
35. Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HE, Cheung CC, Mak TW. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA 2006, 103:1834-1839. 10.1073/pnas.0510847103, 1413671, 16446425.
36. Diamanti-Kandarakis E, Panidis D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol 2007, 67:735-742.
37. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237:E214-E223.
38. Diamanti-Kandarakis E, Kouli C, Alexandraki K, Spina G. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004, 89:1273-1276. 10.1210/jc.2003-031205, 15001622.
39. Diamanti-Kandarakis E, Livadas S, Kandarakis SA, Margeli A, Papassotiriou I. Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?. Eur J Endocrinol 2008, 158:525-531. 10.1530/EJE-07-0822, 18362300.
40. Cakal E, Ozkaya M, Engin-Ustun Y, Ustun Y. Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome. J Endocrinol Invest 2010, e-pub ahead of print 28 May 2007; PMID: 20511727.
41. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94:2493-2503. 10.1172/JCI117619, 330083, 7989608.
42. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, Ueno T, Sugi K, Imaizumi T. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998, 32:368-372. 10.1016/S0735-1097(98)00250-2, 9708462.
43. Tayebjee MH, Lip GY, MacFadyen RJ. Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance. Curr Med Chem 2005, 12:917-925. 10.2174/0929867053507270, 15853705.
44. Tong Z, Wu X, Ovcharenko D, Zhu J, Chen CS, Kehrer JP. Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem J 2005, 391:441-448. 10.1042/BJ20051020, 1276944, 16060857.
45. Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001, 276:37258-37265. 10.1074/jbc.M106089200, 11486009.
46. Leclercq A, Houard X, Philippe M, Ollivier V, Sebbag U, Meilhac O, Michel JB. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol 2007, 82:1420-1429. 10.1189/jlb.1106671, 17827339.
47. Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, Thorén P, Hansson GK. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 2006, 26:136-142. 10.1161/01.ATV.0000193567.88685.f4, 16254208.